Leon Bernal-Mizrachi
Overview
Explore the profile of Leon Bernal-Mizrachi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
2259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Puvvula P, Johnson A, Bernal-Mizrachi L
Oncoscience
. 2024 Jul;
11:58-64.
PMID: 39015604
No abstract available.
2.
Cinar M, Martinez-Medina L, Puvvula P, Arakelyan A, Vardarajan B, Anthony N, et al.
Nucleic Acids Res
. 2024 May;
52(13):7539-7555.
PMID: 38783375
The exchange of genes between cells is known to play an important physiological and pathological role in many organisms. We show that circulating tumor DNA (ctDNA) facilitates cell-specific gene transfer...
3.
Puvvula P, Martinez-Medina L, Cinar M, Feng L, Pisarev A, Johnson A, et al.
Front Oncol
. 2024 Mar;
14:1288724.
PMID: 38463228
Introduction: We have demonstrated that transposons derived from ctDNA can be transferred between cancer cells. The present research aimed to investigate the cellular uptake and intracellular trafficking of Multiple Myeloma-zip...
4.
Cerhan J, Maurer M, Link B, Feldman A, Habermann T, Jaye D, et al.
Am J Hematol
. 2024 Jan;
99(3):408-421.
PMID: 38217361
To address the current and long-term unmet health needs of the growing population of non-Hodgkin lymphoma (NHL) patients, we established the Lymphoma Epidemiology of Outcomes (LEO) cohort study (NCT02736357; https://leocohort.org/)....
5.
Bhutani M, Blue B, Cole C, Badros A, Usmani S, Nooka A, et al.
Blood Cancer J
. 2023 Dec;
13(1):189.
PMID: 38110338
There are significant disparities with regards to incidence, timely diagnosis, access to treatment, clinical trial participation and health care utilization that negatively impact outcomes for African American patients with multiple...
6.
Yu Y, Wade N, Hwang A, Nooka A, Fiala M, Mohrbacher A, et al.
JCO Oncol Pract
. 2020 May;
16(10):e1169-e1180.
PMID: 32469686
Purpose: Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by conventional karyotyping...
7.
Yabroff K, Reeder-Hayes K, Zhao J, Halpern M, Lopez A, Bernal-Mizrachi L, et al.
J Natl Cancer Inst
. 2020 Apr;
112(7):671-687.
PMID: 32337585
Background: Lack of health insurance coverage is associated with poor access and receipt of cancer care and survival in the United States. Disruptions in coverage are common among low-income populations,...
8.
Curry M, Chineke I, Redelico T, Terrell C, Bell W, Flood D, et al.
JCO Oncol Pract
. 2020 Feb;
16(4):e350-e356.
PMID: 32048938
Purpose: Oral anticancer medications (OAMs) offer convenient administration, reducing the burden of cancer treatment, but create challenges for patients and practitioners. Using data from the Quality Oncology Practice Initiative analysis,...
9.
Du Z, Weinhold N, Song G, Rand K, Van Den Berg D, Hwang A, et al.
Blood Adv
. 2020 Jan;
4(1):181-190.
PMID: 31935283
Persons of African ancestry (AA) have a twofold higher risk for multiple myeloma (MM) compared with persons of European ancestry (EA). Genome-wide association studies (GWASs) support a genetic contribution to...
10.
Chineke I, Adams Curry M, Bell W, Flood D, Mishra P, Power S, et al.
JCO Oncol Pract
. 2019 Sep;
16(3):e251-e256.
PMID: 31496391
Purpose: Pain and constipation are common among patients with cancer and remain inadequately controlled in many. The Quality Oncology Practice Initiative assessment of pain and constipation at the Georgia Cancer...